César Núnêz

1.6k total citations
56 papers, 863 citations indexed

About

César Núnêz is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, César Núnêz has authored 56 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 16 papers in Hematology and 14 papers in Genetics. Recurrent topics in César Núnêz's work include Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). César Núnêz is often cited by papers focused on Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (12 papers). César Núnêz collaborates with scholars based in United States, United Kingdom and Barbados. César Núnêz's co-authors include L G Billips, Peter D. Burrows, Max D. Cooper, G. Larry Gartland, Hiromi Kubagawa, Naoki Nishimoto, F. E. Bertrand, J. Richard George, Harrison C. Stetler and Ana K. Stanković and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

César Núnêz

45 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
César Núnêz United States 13 324 158 137 135 119 56 863
Karoline Ehlert Germany 19 210 0.6× 241 1.5× 157 1.1× 253 1.9× 296 2.5× 60 1.1k
Janet Poole South Africa 14 133 0.4× 251 1.6× 116 0.8× 83 0.6× 153 1.3× 29 612
Luisa Strocchio Italy 17 179 0.6× 341 2.2× 117 0.9× 96 0.7× 102 0.9× 43 761
Marlène Pasquet France 20 248 0.8× 285 1.8× 348 2.5× 99 0.7× 184 1.5× 59 1.1k
Catherine Paillard France 19 243 0.8× 390 2.5× 153 1.1× 93 0.7× 237 2.0× 68 973
Hans‐Jürgen Laws Germany 17 386 1.2× 237 1.5× 71 0.5× 279 2.1× 254 2.1× 46 974
Gertjan J. Driessen Netherlands 17 707 2.2× 99 0.6× 89 0.6× 185 1.4× 72 0.6× 30 1.0k
Gertjan J. Driessen Netherlands 14 615 1.9× 68 0.4× 111 0.8× 206 1.5× 134 1.1× 29 1.1k
Manuel Abecasis Portugal 11 198 0.6× 488 3.1× 131 1.0× 230 1.7× 220 1.8× 24 865
Cindy McGrath United States 21 187 0.6× 121 0.8× 103 0.8× 461 3.4× 356 3.0× 45 1.4k

Countries citing papers authored by César Núnêz

Since Specialization
Citations

This map shows the geographic impact of César Núnêz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Núnêz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Núnêz more than expected).

Fields of papers citing papers by César Núnêz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Núnêz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Núnêz. The network helps show where César Núnêz may publish in the future.

Co-authorship network of co-authors of César Núnêz

This figure shows the co-authorship network connecting the top 25 collaborators of César Núnêz. A scholar is included among the top collaborators of César Núnêz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César Núnêz. César Núnêz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corrigan, Kelsey L., Amy M. Berkman, Jillian R. Gunther, et al.. (2025). Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 34(9). 1483–1491.
2.
Berkman, Amy M., Clark R. Andersen, Nicholas J. Short, et al.. (2025). Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum. 9(4).
3.
4.
McCall, David, César Núnêz, Michael Roth, et al.. (2025). Post transplant maintenance therapy with newly FDA-approved revumenib for high-risk KMT2Ar acute leukemia. Blood Advances. 9(8). 1988–1990. 1 indexed citations
5.
6.
McCall, David, Ramya Ramakrishnan, César Núnêz, et al.. (2024). Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience. Cancers. 16(22). 3886–3886. 1 indexed citations
7.
McCall, David, César Núnêz, Michael Roth, et al.. (2024). Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia. Cancers. 16(5). 858–858. 3 indexed citations
8.
9.
McCall, David, César Núnêz, Michael Roth, et al.. (2023). Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies. Translational Pediatrics. 12(3). 487–502. 7 indexed citations
10.
McCall, David, Michael Roth, Kris M. Mahadeo, et al.. (2021). Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia. Blood Advances. 5(23). 5215–5219. 6 indexed citations
11.
McCall, David, Sajad Khazal, Michael Roth, et al.. (2021). Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers. 14(1). 150–150. 41 indexed citations
12.
Ragoonanan, Dristhi, César Núnêz, Michael Roth, et al.. (2021). DNMT3A Mutations Should be Considered in the Risk Stratification for Pediatric and Adolescent and Young Adult Patients with Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1308–1308.
13.
Tambaro, Francesco Paolo, Sajad Khazal, César Núnêz, et al.. (2020). Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy. SHILAP Revista de lepidopterología. 8(9). 1678–1681. 7 indexed citations
14.
Núnêz, César, Priti Tewari, Demetrios Petropoulos, et al.. (2020). Primary mediastinal large B‐cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy. British Journal of Haematology. 190(2). e114–e117. 3 indexed citations
15.
Samra, Bachar, Hagop M. Kantarjian, Koji Sasaki, et al.. (2020). Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant. Acta Haematologica. 144(3). 285–292. 12 indexed citations
16.
Landis, R. Clive, George Janossy, Patrice Joseph, et al.. (2018). Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017. AIDS Research and Human Retroviruses. 34(7). 561–569. 4 indexed citations
17.
Lewis, Daniel J., Julia Dai, Priyadharsini Nagarajan, et al.. (2017). An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD Case Reports. 3(4). 276–279. 1 indexed citations
18.
Núñez, Rafael, et al.. (1998). Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunology Letters. 61(1). 33–43. 7 indexed citations
19.
Candal, Debra, Chou‐Pong Pau, C C Luo, et al.. (1997). Genetic Variability of HIV Type 1 in Honduras. AIDS Research and Human Retroviruses. 13(15). 1349–1350. 2 indexed citations
20.
Núnêz, César, Naoki Nishimoto, G. Larry Gartland, et al.. (1996). B cells are generated throughout life in humans. The Journal of Immunology. 156(2). 866–872. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karoline Ehlert Breakdown of academic impact, for papers by Janet Poole Breakdown of academic impact, for papers by Luisa Strocchio Breakdown of academic impact, for papers by Marlène Pasquet Breakdown of academic impact, for papers by Catherine Paillard Breakdown of academic impact, for papers by Hans‐Jürgen Laws Breakdown of academic impact, for papers by Gertjan J. Driessen Breakdown of academic impact, for papers by Gertjan J. Driessen Breakdown of academic impact, for papers by Manuel Abecasis Breakdown of academic impact, for papers by Cindy McGrath
Rankless by CCL
2026